Role of circ_0002590 in Neuroinflammation Via the miR-1184/NLRP1 Axis in Painful Diabetic Neuropathy
Experimental and Clinical Endocrinology & Diabetes · 01.08.2025 · 133 (08) · 415-424
DOI: 10.1055/a-2676-1452 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, erschienen am 01.08.2025. Verfasst von Qiao Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China. Hauptthemen laut MEDLINE: MicroRNAs, RNA, Circular, Diabetic Neuropathies, NLR Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: The second batch of social development-related science and technology projects in Taizhou City in 2022 (22ywb25).
Abstract (Originalsprache)
Painful diabetic neuropathy (PDN), a severe microvascular complication of diabetes, is closely associated with neuroinflammation. This study aimed to investigate the mechanism of circ_0002590 in neuroinflammation associated with PDN. The Schwann cells (HEI193) were treated with high glucose (HG, 150 mM) to simulate the diabetic microenvironment. Circ_0002590 expression was silenced using siRNA interference technology and was determined by quantitative real-time reverse transcription polymerase chain reaction. Inflammatory cytokines levels were measured by enzyme-linked immunosorbent assay. The cell counting kit-8 assay was utilized to determine cellular viability. Bioinformatic predictions (TargetScan 8.0 and circRNA Interactome databases) combined with dual-luciferase reporter gene assays and RNA pull-down assays were employed to validate the correlation linking circ_0002590 and miR-1184, as well as between miR-1184 and Nod-like receptor pyrin domain-containing 1 (NLRP1). Rescue assays were performed to confirm the function of the circ_0002590/miR-1184/NLRP1 competing endogenous RNA (ceRNA) network in PDN-associated neuroinflammation. HG treatment significantly upregulated circ_0002590 expression in HEI193 cells, promoted inflammatory cytokine release, and reduced cell viability. These effects were reversed after circ_0002590 silencing. Circ_0002590 directly interacted with miR-1184 and suppressed miR-1184 expression. miR-1184 targeted and inhibited NLRP1 expression. miR-1184 inhibition or NLRP1 overexpression reversed the anti-inflammatory effects mediated by circ_0002590 silencing. HG activates the inflammatory response in Schwann cells by inducing circ_0002590 expression, which competitively binds with miR-1184 and thereby alleviates its inhibitory effect on NLRP1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China.
ORCID-Profile: Ping Feng
Förderung
- The second batch of social development-related science and technology projects in Taizhou City in 2022 (22ywb25)
Zitieren
APA
Liu, Q., Chen, M., Cai, X., & Feng, P. (2025). Role of circ_0002590 in Neuroinflammation Via the miR-1184/NLRP1 Axis in Painful Diabetic Neuropathy. Experimental and Clinical Endocrinology & Diabetes, 133(08), 415-424. https://doi.org/10.1055/a-2676-1452
Vancouver
Liu Q, Chen M, Cai X, Feng P. Role of circ_0002590 in Neuroinflammation Via the miR-1184/NLRP1 Axis in Painful Diabetic Neuropathy. Experimental and Clinical Endocrinology & Diabetes. 2025;133(08):415-424. doi:10.1055/a-2676-1452
BibTeX
@article{Liu2025,
author = {Liu, Qiao and Chen, Mengdie and Cai, Xinxiao and Feng, Ping},
title = {Role of circ_0002590 in Neuroinflammation Via the miR-1184/NLRP1 Axis in Painful Diabetic Neuropathy},
journal = {Experimental and Clinical Endocrinology & Diabetes},
year = {2025},
volume = {133},
number = {08},
pages = {415--424},
doi = {10.1055/a-2676-1452}
}
EUVIMED